Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Sept 2026 for Definium Therapeutics, Inc., €34k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Carol A. Vallone: trading record in brief
Carol A. Vallone is a declared insider of Definium Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 1 June 2022 to 18 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 18 September 2026 came the latest disclosure, an option exercise for €34k in Definium Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Carol A. Vallone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,086 shares@ US$35.52Common SharesSEC:0001193125-26-395892:0
4,666 sharesCommon SharesSEC:0001193125-26-271160:0
13,671 shares0Common SharesSEC:0000899243-23-016419:0
43,104 shares0Subordinate Voting SharesSEC:0001209191-22-034501:0
43,104 shares0Subordinate Voting SharesSEC:0001209191-22-034419:0
5 of 5 declarations
